96 related articles for article (PubMed ID: 6504495)
1. Aminoglutethimide-induced leukopenia: a case report and review of the literature.
Gez E; Sulkes A
Oncology; 1984; 41(6):399-402. PubMed ID: 6504495
[TBL] [Abstract][Full Text] [Related]
2. Leukopenia associated with aminoglutethimide therapy: a case report.
Austerlitz J
Cancer Treat Rep; 1982 Oct; 66(10):1879. PubMed ID: 7127328
[No Abstract] [Full Text] [Related]
3. Aminoglutethimide-induced hematologic toxicity: worldwide experience.
Messeih AA; Lipton A; Santen RJ; Harvey HA; Boucher AE; Murray R; Ragaz J; Buzdar AU; Nagel GA; Henderson IC
Cancer Treat Rep; 1985 Sep; 69(9):1003-4. PubMed ID: 4028032
[TBL] [Abstract][Full Text] [Related]
4. Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature.
Young JA; Newcomer LN; Keller AM
Cancer; 1984 Oct; 54(8):1731-3. PubMed ID: 6478412
[TBL] [Abstract][Full Text] [Related]
5. Severe leukopenia induced by aminoglutethimide.
Kampel LJ; Kurman MR
Cancer Treat Rep; 1984 Oct; 68(10):1277-8. PubMed ID: 6525598
[No Abstract] [Full Text] [Related]
6. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
[TBL] [Abstract][Full Text] [Related]
7. Aminoglutethimide as second line therapy in advanced breast cancer.
Elomaa I; Blomqvist C; Rissanen P
Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
[TBL] [Abstract][Full Text] [Related]
8. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
Paridaens R; Van Haelen C; Heuson JC
Eur J Cancer (1965); 1980; Suppl 1():103-6. PubMed ID: 7318860
[No Abstract] [Full Text] [Related]
9. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of metastasizing breast cancer with aminoglutethimide].
Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
[TBL] [Abstract][Full Text] [Related]
11. Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer.
Bruning PF; Bonfrèr JG; Engelsman E; Hamersma-vd Linden E; de Jong-Bakker M; Nooyen W
Breast Cancer Res Treat; 1984; 4(4):289-95. PubMed ID: 6518295
[TBL] [Abstract][Full Text] [Related]
12. Aminoglutethimide as second-line hormonal therapy in advanced breast cancer: response and toxicity.
Rowell NP; Gilmore OJ; Plowman PN
Hum Toxicol; 1987 May; 6(3):227-32. PubMed ID: 3596607
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
[TBL] [Abstract][Full Text] [Related]
14. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
Sterns EE; Bird CE; Mackie KW
Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
[TBL] [Abstract][Full Text] [Related]
15. Aminoglutethimide (AG) and hydrocortisone (HC) in bone metastases: a retrospective study.
Bonneterre J; Adenis A; Pion JM; Cambier L; Kamus E; Hecquet B
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):693-6. PubMed ID: 8476786
[TBL] [Abstract][Full Text] [Related]
16. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.
Vincent MD; Clink HM; Coombes RC; Smith IE; Kandler R; Powles TJ
Br Med J (Clin Res Ed); 1985 Jul; 291(6488):105-6. PubMed ID: 2990631
[No Abstract] [Full Text] [Related]
17. Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report.
Coombes RC; Chilvers C; Dowsett M; Gazet JC; Ford HT; Bettelheim R; Gordon C; Smith IE; Zava D; Powles TJ
Cancer Res; 1982 Aug; 42(8 Suppl):3415s-3419s. PubMed ID: 6211228
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized study of aminoglutethimide (AG) versus medroxyprogesterone acetate (MPA) versus AG+MPA in generalized breast cancer.
Samonis G; Margioris AN; Bafaloukos D; Razis DV
Oncology; 1994; 51(5):411-5. PubMed ID: 8052481
[TBL] [Abstract][Full Text] [Related]
19. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
[TBL] [Abstract][Full Text] [Related]
20. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
Nadezhdina TM; Vyshinskaia GV; Lichinitser MR; Bassalyk LS; Garin AM
Vopr Onkol; 1987; 33(5):79-82. PubMed ID: 3590672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
